comparemela.com

Latest Breaking News On - Debra patt - Page 7 : comparemela.com

Patt Highlights Payer, Education Considerations in Trastuzumab Deruxtecan Use for HER2-Low Breast Cancer

At Patient-Centered Oncology CareĀ®, Debra Patt, MD, PhD, MBA, of Texas Oncology, discussed managed care considerations that arise from the groundbreaking DESTINY-Breast04 study presented earlier this year.

COA to Celebrate 20 Years of Advocacy at Annual Conference

Topics to be addressed at the annual conference, which will bring more than 1900 attendees to Kissimmee, Florida, include the Enhancing Oncology Model, efforts to regulate pharmacy benefit managers, and 340B reform.

vimarsana © 2020. All Rights Reserved.